Viewing records where tag name contains "reports"
View All
Quarterly Activities Report & Appendix 4C (ASX Announcement)
Apr 28th, 2023
Starpharma (ASX: SPL, OTCQX: SPHRY) today releases its Quarterly Activities Report and Appendix 4C for the period ended 31 March 2023 (Q3 FY23). Starpharma’s net operating cash outflows for the quarter were $4.9 million, and the closing cash balance as at 31 March 2023 was $38.9 million.
Read More
2022 Annual General Meeting - CEO's presentation
Dec 2nd, 2022
View/Download a copy of the CEO's presentation to shareholders at the 2022 Annual General Meeting, held on 29 November 2022.
Read More
Starpharma annual report and full year financial results
Aug 25th, 2022
Starpharma today released its annual report and financial results for the year ended 30 June 2022.
Read More